The COVID-19 pandemic has placed vaccine science in the limelight and acutely demonstrated how vaccines can save lives and societies. The rapid advances in vaccine science spurred by the COVID-19 pandemic were built on a solid foundation of infectious disease research and provide promise for better ways of fighting new and existing infectious diseases. However, there is still substantial progress to be made in promoting long-term immunity, combatting vaccine inequity, and ensuring epidemic preparedness.
This lecture is organized in a collaboration between Bioscience Cluster and a new department at the Novo Nordisk foundation, Infectious Diseases.
The first talk by Peter Lawætz Andersen, who is the director of Infectious Diseases, will provide a historical perspective of vaccine science and discuss how COVID-19 was a game-changer for vaccine science. The second talk by Ingrid Kromann will provide an overview of how The Coalition for Epidemic Preparedness Innovations (CEPI) aims to promote vaccine access to all and ensure that societies are well-equipped for the next pandemic threat.
The lecture will, as always, be available to both physical and online attendance.
Date: 25 November 2021
Time: 16:00 – 17:30 CET
Venue: Novo Nordisk Foundation, Tuborg Havnevej 19, 2900 Hellerup
|15:45||Arrival and Registration|
|16:05||Vaccines – how did it start and how did Covid-19 change vaccine technology|
Peter Lawætz Andersen, Professor of Immunology at University of Copenhagen and Senior Project Director, Infectious Diseases, Novo Nordisk Fonden
|16:45||New Vaccines for a safer world – Speed is of the essence in outbreak response|
Ingrid Kromann, Head of CMC at CEPI (Coalition for Epidemic Preparedness Innovations)
|17:30||Networking with drinks and snacks for physical participants|
|18:30||Thank you for today!|
*Please note that the program might be subject to changes